University of Birmingham: A Third of Leukaemia Patients Do Not Generate Any Antibody Response to Two Doses of COVID-19 Vaccination, Study Shows
October 23, 2021
October 23, 2021
BIRMINGHAM, England, Oct. 23 (TNSRes) -- The University of Birmingham issued the following news release:
A University of Birmingham-led study has shown that a third of patients with the most common type of leukaemia fail to generate any measurable antibody response following two doses of COVID-19 vaccination.
Furthermore, the research showed that in the two thirds of patients who do develop antibodies, levels are much lower than compared to healthy people and also have . . .
A University of Birmingham-led study has shown that a third of patients with the most common type of leukaemia fail to generate any measurable antibody response following two doses of COVID-19 vaccination.
Furthermore, the research showed that in the two thirds of patients who do develop antibodies, levels are much lower than compared to healthy people and also have . . .